A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines

Trial Profile

A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2014

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Headache; Migraine
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 31 Jan 2014 According to ClinicalTrials.gov record trial status changed from suspended to withdrawn prior to recruitment.
    • 13 Jun 2013 Planned end date changed from 1 Mar 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 13 Jun 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top